The UFC has released a statement regarding Anderson Silva’s recent suspension stemming from an out-of-competition sample collected a few weeks ago.
Just minutes ago, the UFC dropped a bombshell statement: Anderson Silva has been flagged for another potential doping violation stemming from an out-of-competition sample collected this past October 26, 2017. Silva isn’t even three years out from his last test failures which included several different substances over the course of two sample collections by the Nevada Athletic Commission:
Jan 9, 2015: two anabolic androgenic steroids in an out-of-competition test – drostanolone and androstane
Jan 31st, 2015: drostanolone (again) on his in-competition test, as well as temazepam and oxazepam, which are both benzodiazepines and also banned in-competition
The UFC’s statement is as follows:
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Anderson Silva of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on October 26, 2017. As a result, Silva has been provisionally suspended by USADA. Due to the proximity of Silva’s upcoming scheduled bout at UFC Fight Night, Shanghai, China on November 25, 2017 against Kelvin Gastelum, Silva has been removed from the card and UFC is currently seeking a replacement.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Silva. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. Additional information will be provided at the appropriate time as the process moves forward.
Silva was scheduled to face Kelvin Gastelum on the UFC’s inaugural Shanghai card this Novemer 25th. The UFC has not yet addressed that issue. Keep your browser locked on BloodyElbow.com for more on this story, as we’ll be updating it as more information becomes available.